Lori M. van Roozendaal

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

Lori M. van Roozendaal, M. Vane, Thijs van Dalen et al. · BMC Cancer · 2017 · 183 citations · Full text

Medicine, Oncology, Surgery +10

Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research

M. Moossdorff, Lori M. van Roozendaal, Luc J. A. Strobbe et al. · JNCI Journal of the National Cancer Institute · 2014 · 118 citations · Full text

Medicine, Oncology, Breast Oncology +5

Axillary ultrasound for preoperative nodal staging in breast cancer patients: Is it of added value?

Robert‐Jan Schipper, Lori M. van Roozendaal, Bart de Vries et al. · The Breast · 2013 · 84 citations · Full text

Medicine, Oncology, Surgery +16

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)

Lori M. van Roozendaal, Johannes HW de Wilt, Thijs van Dalen et al. · BMC Cancer · 2015 · 81 citations · Full text

Medicine, Oncology, Surgery +16

Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study

Lori M. van Roozendaal, Leonie Smit, Gaston H. N. M. Duijsens et al. · Breast Cancer Research and Treatment · 2016 · 81 citations · Full text

Medicine, Oncology, Surgery +14